1/17/2024
University of Virginia School of Medicine researchers have received $3.1 million from the National Institutes of Health’s National Cancer Institute to pioneer the use of focused soundwaves to improve treatment…
Research in Motion: Hongji Zhang, PhD
1/17/2024
As a cancer immunologist, my research revolves around understanding the role of the tumor microenvironment in various oncologic disease processes, such as colorectal cancer and liver cancer; and providing novel…
iTHRIV Offers New Funding Opportunity
1/10/2024
The iTHRIV Clinical and Translational Science (CTS) Pilot Studies Program announces $200,000 in available funding to support innovative approaches to translational science projects (TS), and to foster research collaborations across…
UVA Researchers Seek to Save Children From Deadly Diarrhea in New International Effort
1/10/2024
UVA researchers have joined a new international consortium that will work to understand how climate change could affect dangerous diarrheal diseases, a leading cause of death for children under 5…
Xinxin Chen, PhD, Awarded the 2023 American Diabetes Association Postdoctoral Fellowship
1/10/2024
Postdoctoral Fellow Xinxin Chen, PhD, of the Qi laboratory in the Department of Molecular Physiology and Biological Physics, was awarded the 2023 American Diabetes Association (ADA) Postdoctoral Fellowship. This five-year…
UVA Discovery Could Help Prevent Major Cause of Deaths Following Lung Transplant
1/10/2024
University of Virginia School of Medicine researchers have identified a potential way to improve the success of lung transplants by preventing damage caused when blood flow is restored to the…
1/10/2024
Irving Kron, MD, and Vic Laubach, PhD, professors in the Department of Surgery, were awarded a 4-year, $3.1 million grant from the NIH to study groundbreaking, perfusion-based methods to treat…
Research in Motion: Michael E. Williams, MD
1/10/2024
My work is focused on lymphoma; specifically, understanding the molecular underpinnings that drive these cancers, and also employing and testing in clinical research novel targeted agents and immunotherapies that are…
